Paroxysmal AV Block other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Paroxysmal AV block}} | |||
{{CMG}}; {{AE}}{{Akash}} | |||
==Overview== | ==Overview== | ||
[[Cardiac]] [[nuclear imaging]] techniques can be useful to detect and/or discriminate amongst infiltrative cardiomyopathies. | [[Cardiac]] [[nuclear imaging]] techniques can be useful to detect and/or discriminate amongst infiltrative cardiomyopathies. | ||
Line 7: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Cardiology]] | |||
[[Category:Cardiovascular diseases]] | |||
[[Category:Arrythmia]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 07:57, 11 July 2020
Paroxysmal AV block Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Paroxysmal AV Block other imaging findings On the Web |
American Roentgen Ray Society Images of Paroxysmal AV Block other imaging findings |
Risk calculators and risk factors for Paroxysmal AV Block other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
Cardiac nuclear imaging techniques can be useful to detect and/or discriminate amongst infiltrative cardiomyopathies.
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay[1]
- Cardiac nuclear imaging techniques help diagnose infiltrative cardiomyopathies, most notably in distinguishing between wild-type transthyretin and light chain cardiac amyloidosis and sarcoidosis.
References
- ↑ Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR; et al. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society". J Am Coll Cardiol. 74 (7): 932–987. doi:10.1016/j.jacc.2018.10.043. PMID 30412710.